Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors

Detalhes bibliográficos
Autor(a) principal: Valadares, Ana Lúcia Ribeiro, 1954-
Data de Publicação: 2016
Outros Autores: Moraes, Monica Jacques de, Pinto-Neto, Aarão Mendes, 1952-2015, Costa-Paiva, Lucia, 1958-
Tipo de documento: Artigo
Título da fonte: Repositório da Produção Científica e Intelectual da Unicamp
Texto Completo: https://hdl.handle.net/20.500.12733/638
Resumo: Abstract: To determine the prevalence of metabolic syndrome (MetS) and its associated factors in a group of HIV-infected middle-aged women. Cross-sectional study including 273 HIV-infected climacteric women of 40–60 years of age under care in two HIV outpatient reference centers in Brazil. Metabolic syndrome diagnosis was based on 2006 International Diabetes Federation criteria. Sociodemographic, clinical and behavioral factors were evaluated as well as HIV infection-related parameters. Mean age was 47.7 years; 59.1% of women were premenopausal, 91% were on antiretroviral therapy. Current CD4 count was >500 cells/mm 3 in 61.7%, current viral load undetectable in 76.9% of women, and a quarter had previous diagnosis of aids. The prevalence of metabolic syndrome in the subgroup of menopausal women was 46.9%. Univariate analysis showed an association between metabolic syndrome and age =50 years ( p = 0.002), schooling <8 years ( p = 0.003), post-menopause ( p < 0.001), body mass index (BMI) >25 kg/m 2 ( p < 0.001), and FSH =40 mIU/mL ( p = 0.002). In the multivariate analysis only increased BMI (PR = 1.09; 95% CI: 1.05–1.13; p < 0.001) and FSH levels =40 mIU/mL (PR = 1.66; 95% CI: 1.14–2.40; p = 0.008) maintained statistical significance. There was no association between PI use or any other factor related to HIV-infection and MetS in any of the analyses performed. High BMI and FSH levels compatible with menopause were the only factors associated with MetS in these middle aged HIV-infected women. In the context of well-controlled, early treated HIV infection, traditional rather than HIV-related factors were associated with MetS
id CAMP_f9f87190fe8bc698ea6ec374bf803173
oai_identifier_str oai:https://www.repositorio.unicamp.br/:1231905
network_acronym_str CAMP
network_name_str Repositório da Produção Científica e Intelectual da Unicamp
repository_id_str
spelling Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factorsSíndrome metabólicaMetabolic syndromeMenopauseHIVProtease inhibitorsArtigo originalAbstract: To determine the prevalence of metabolic syndrome (MetS) and its associated factors in a group of HIV-infected middle-aged women. Cross-sectional study including 273 HIV-infected climacteric women of 40–60 years of age under care in two HIV outpatient reference centers in Brazil. Metabolic syndrome diagnosis was based on 2006 International Diabetes Federation criteria. Sociodemographic, clinical and behavioral factors were evaluated as well as HIV infection-related parameters. Mean age was 47.7 years; 59.1% of women were premenopausal, 91% were on antiretroviral therapy. Current CD4 count was >500 cells/mm 3 in 61.7%, current viral load undetectable in 76.9% of women, and a quarter had previous diagnosis of aids. The prevalence of metabolic syndrome in the subgroup of menopausal women was 46.9%. Univariate analysis showed an association between metabolic syndrome and age =50 years ( p = 0.002), schooling <8 years ( p = 0.003), post-menopause ( p < 0.001), body mass index (BMI) >25 kg/m 2 ( p < 0.001), and FSH =40 mIU/mL ( p = 0.002). In the multivariate analysis only increased BMI (PR = 1.09; 95% CI: 1.05–1.13; p < 0.001) and FSH levels =40 mIU/mL (PR = 1.66; 95% CI: 1.14–2.40; p = 0.008) maintained statistical significance. There was no association between PI use or any other factor related to HIV-infection and MetS in any of the analyses performed. High BMI and FSH levels compatible with menopause were the only factors associated with MetS in these middle aged HIV-infected women. In the context of well-controlled, early treated HIV infection, traditional rather than HIV-related factors were associated with MetSFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESPAbertoUNIVERSIDADE ESTADUAL DE CAMPINASValadares, Ana Lúcia Ribeiro, 1954-Moraes, Monica Jacques dePinto-Neto, Aarão Mendes, 1952-2015Costa-Paiva, Lucia, 1958-2016info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.12733/638VALADARES, Ana Lúcia Ribeiro et al. Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy: prevalence and associated factors. Brazilian journal of infectious diseases. Barcelona : Elsevier, 2016. Vol. 21, n. 3 (2016), p. 263-269. Disponível em: https://hdl.handle.net/20.500.12733/638. Acesso em: 24 mai. 2023.Inglêshttps://repositorio.unicamp.br/acervo/detalhe/1231905reponame:Repositório da Produção Científica e Intelectual da Unicampinstname:Universidade Estadual de Campinas (UNICAMP)instacron:UNICAMPinfo:eu-repo/semantics/openAccess2021-11-16T15:04:38Zoai:https://www.repositorio.unicamp.br/:1231905Repositório InstitucionalPUBhttp://repositorio.unicamp.br/oai/requestreposip@unicamp.bropendoar:2021-11-16T15:04:38Repositório da Produção Científica e Intelectual da Unicamp - Universidade Estadual de Campinas (UNICAMP)false
dc.title.none.fl_str_mv Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors
title Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors
spellingShingle Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors
Valadares, Ana Lúcia Ribeiro, 1954-
Síndrome metabólica
Metabolic syndrome
Menopause
HIV
Protease inhibitors
Artigo original
title_short Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors
title_full Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors
title_fullStr Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors
title_full_unstemmed Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors
title_sort Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy : prevalence and associated factors
author Valadares, Ana Lúcia Ribeiro, 1954-
author_facet Valadares, Ana Lúcia Ribeiro, 1954-
Moraes, Monica Jacques de
Pinto-Neto, Aarão Mendes, 1952-2015
Costa-Paiva, Lucia, 1958-
author_role author
author2 Moraes, Monica Jacques de
Pinto-Neto, Aarão Mendes, 1952-2015
Costa-Paiva, Lucia, 1958-
author2_role author
author
author
dc.contributor.none.fl_str_mv UNIVERSIDADE ESTADUAL DE CAMPINAS
dc.contributor.author.fl_str_mv Valadares, Ana Lúcia Ribeiro, 1954-
Moraes, Monica Jacques de
Pinto-Neto, Aarão Mendes, 1952-2015
Costa-Paiva, Lucia, 1958-
dc.subject.por.fl_str_mv Síndrome metabólica
Metabolic syndrome
Menopause
HIV
Protease inhibitors
Artigo original
topic Síndrome metabólica
Metabolic syndrome
Menopause
HIV
Protease inhibitors
Artigo original
description Abstract: To determine the prevalence of metabolic syndrome (MetS) and its associated factors in a group of HIV-infected middle-aged women. Cross-sectional study including 273 HIV-infected climacteric women of 40–60 years of age under care in two HIV outpatient reference centers in Brazil. Metabolic syndrome diagnosis was based on 2006 International Diabetes Federation criteria. Sociodemographic, clinical and behavioral factors were evaluated as well as HIV infection-related parameters. Mean age was 47.7 years; 59.1% of women were premenopausal, 91% were on antiretroviral therapy. Current CD4 count was >500 cells/mm 3 in 61.7%, current viral load undetectable in 76.9% of women, and a quarter had previous diagnosis of aids. The prevalence of metabolic syndrome in the subgroup of menopausal women was 46.9%. Univariate analysis showed an association between metabolic syndrome and age =50 years ( p = 0.002), schooling <8 years ( p = 0.003), post-menopause ( p < 0.001), body mass index (BMI) >25 kg/m 2 ( p < 0.001), and FSH =40 mIU/mL ( p = 0.002). In the multivariate analysis only increased BMI (PR = 1.09; 95% CI: 1.05–1.13; p < 0.001) and FSH levels =40 mIU/mL (PR = 1.66; 95% CI: 1.14–2.40; p = 0.008) maintained statistical significance. There was no association between PI use or any other factor related to HIV-infection and MetS in any of the analyses performed. High BMI and FSH levels compatible with menopause were the only factors associated with MetS in these middle aged HIV-infected women. In the context of well-controlled, early treated HIV infection, traditional rather than HIV-related factors were associated with MetS
publishDate 2016
dc.date.none.fl_str_mv 2016
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/20.500.12733/638
VALADARES, Ana Lúcia Ribeiro et al. Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy: prevalence and associated factors. Brazilian journal of infectious diseases. Barcelona : Elsevier, 2016. Vol. 21, n. 3 (2016), p. 263-269. Disponível em: https://hdl.handle.net/20.500.12733/638. Acesso em: 24 mai. 2023.
url https://hdl.handle.net/20.500.12733/638
identifier_str_mv VALADARES, Ana Lúcia Ribeiro et al. Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy: prevalence and associated factors. Brazilian journal of infectious diseases. Barcelona : Elsevier, 2016. Vol. 21, n. 3 (2016), p. 263-269. Disponível em: https://hdl.handle.net/20.500.12733/638. Acesso em: 24 mai. 2023.
dc.language.iso.fl_str_mv Inglês
language_invalid_str_mv Inglês
dc.relation.none.fl_str_mv https://repositorio.unicamp.br/acervo/detalhe/1231905
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório da Produção Científica e Intelectual da Unicamp
instname:Universidade Estadual de Campinas (UNICAMP)
instacron:UNICAMP
instname_str Universidade Estadual de Campinas (UNICAMP)
instacron_str UNICAMP
institution UNICAMP
reponame_str Repositório da Produção Científica e Intelectual da Unicamp
collection Repositório da Produção Científica e Intelectual da Unicamp
repository.name.fl_str_mv Repositório da Produção Científica e Intelectual da Unicamp - Universidade Estadual de Campinas (UNICAMP)
repository.mail.fl_str_mv reposip@unicamp.br
_version_ 1766887322044858368